Philips teams up with Genomic Health to utilize innovative digital pathology solutions to optimize pre-analytical specimen processing

2 mins read

The FINANCIAL — Royal Philips on October 12 announced a collaboration with Genomic Health, Inc., one of the world leading providers of genomic-based diagnostic tests, to leverage Philips’ digital pathology tools in Genomic Health’s continuing scale up of its molecular diagnostic testing processes.   

Pathology involves the examination of patient tissue samples and plays a crucial role in the diagnosis and treatment of a wide variety of diseases, including cancer. Philips is a pioneer and leader in the digitization of pathology. Pathologic evaluation of tumor tissue specimens is a critical step in the genomic testing process conducted by Genomic Health’s Clinical Reference Laboratory. These genomic tests support physicians’ ability to deliver personalized treatment for patients diagnosed with complex disease such as cancer, according to Philips.

“Digitization has the potential to open new opportunities for increased efficiency and a reduction in the shortcomings of a traditional analog histopathology workflow,” said Russell Granzow, General Manager of Philips Digital Pathology Solutions. “Philips is driving the evolution towards unified patient data to ensure pathologists are empowered to meet the increasing demand in cancer care for more precise diagnostics.”

“By utilizing Philips’ latest digital pathology solution, we are providing our pathologists with a state-of-the-art system that will provide the next level of scalability and efficiency for our overall pre-analytical process, adding new capabilities that will be increasingly important as worldwide demand for Genomic Health’s tests continues to grow,” said Jon Cassel, Senior Vice President of Operations at Genomic Health.


See also  Why is Wondershare Filmora the Best Video Editors for Beginners?

Leave a Reply